COVID-19 Vaccine Tracker: Adverse Events Reported Across Country

With two approved COVID-19 vaccines, one crore health workers will first receive the vaccine shots

India has reported more than 1.1 crore positive cases of COVID-19 since January 30, 2020. With over 1.5 lakh deaths and nearly 97% of the positive cases having recovered, India has now approved two vaccines to be given to 30 crore of its population.

In the first phase, the government intends to vaccinate over one crore health workers followed by two crore other frontline workers. The Centre will bear the cost of vaccinating these three crore COVID-19 warriors.

Around 27 crore people older than the age of 50 as well as those living with severe co-morbidities under the age of 50 will be vaccinated in the upcoming year.



Updated On: 2021-01-21T19:30:50+05:30

Live Updates

  • 21 Jan 2021 1:50 PM GMT

    1 Hospitalisation, Over 9 lakh Vaccinated

    On the sixth day of COVID-19 vaccination, India vaccinated over 2,12,223 beneficiaries till 6 pm taking the total number of health workers who received vaccination to 9,99,065. 

    There were no adverse events following immunization reported in the country, today. One person was hospitalised after receiving their first shot which the Health Ministry stated is not related to vaccination and no deaths were reported today. 


  • 20 Jan 2021 2:39 PM GMT

    COWIN app updated

    For further smoothening the COVID-19 vaccination process, the Ministry of Health and Family Welfare has brought about some enhancements to the COWIN application. 

    Along with providing a pre-registered list of beneficiaries for specific sessions, the app now allows a new allotment wherein new beneficiaries can be selected to receive the vaccine in an ongoing session if they are not previously listed for the session. 

    Beneficiaries will receive a provisional certificate after receiving the first dose and a final certificate after the second dose. 

  • 20 Jan 2021 2:23 PM GMT

    10 hospitalisations, over 7 lakh vaccinated

    On the fifth day of COVID-19 vaccination, India vaccinated over 1,12,007 beneficiaries till 6 pm taking the total number of health workers who received vaccination to 7,86, 842. 

    Close to 10 people have been hospitalised following vaccination. While one person each in Uttarakhand, Chhattisgarh, Rajasthan, and three in Delhi have been discharged, one person in Delhi, two in Karnataka, and one in West Bengal are still under observation

  • 20 Jan 2021 2:15 PM GMT

    Four deaths after COVID-19 vaccination

    Four health workers have died post receiving COVID-19 vaccination across the country. The government, however, believes that none of the deaths were due to vaccination. 

    One person died each in Telangana and Uttar Pradesh, while two deaths occurred in Karnataka. 

  • 19 Jan 2021 2:03 PM GMT

    Over 6 lakh health workers vaccinated

    Around 6,31,417 health workers have received either of the COVID- 19 vaccines in the country. On January 19, a total of 1.7 lakh health workers received vaccination. 

    There were no adverse events following immunization reported in the country, today. Around nine people had to be hospitalised after receiving their first shot. 

  • 19 Jan 2021 1:59 PM GMT

    India To Export COVID- 19 Vaccine To Neighbouring Countries

    India is set to export doses of the COVID-19 vaccine to Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles will begin from 20 January 2021.

    In respect of Sri Lanka, Afghanistan and Mauritius, we are awaiting their confirmation of necessary regulatory clearances. 

    This aligns with India's goals to fight this pandemic, the Ministry of External Affairs stated in a press release. 

    The government will ensure that the domestic manufacturers will have adequate stocks to meet domestic requirements while supplying abroad.

  • 19 Jan 2021 12:31 PM GMT

    India Considering A Nasal COVID-19 Vaccine

    A nasal COVID-19 vaccine produced by Bharat Biotech has been identified by the Indian Council of Medical Research, NITI Aayog, and the Ministry of Health and Family Welfare as a potential vaccine candidate for India, announced Dr. V.K.Paul, member NITI Aayog. The vaccine manufacturer has approached the Central Drugs Standard Control Organisation for approval to begin Phase I/II trials in the country. 

    Nasal vaccines have been used to tackle rotavirus before. 

  • 19 Jan 2021 12:05 PM GMT

    Three Documents Shared With COVAXIN

    As COVAXIN is under restricted use for emergency situations and under the clinical trial mode, every participant who receives this vaccine is being given three documents along with the vaccine shot. A fact sheet in all regional languages that describes the vaccine and who is eligible to receive it, an informed consent sheet that the recipients are expected to sign, and a form for filling in details of any adverse events following immunisation. 

    The form for AEFI has to be filled by the beneficiaries after a designated doctor calls them daily for seven days as follow up to check for any side effects after immunisation.  

  • 19 Jan 2021 11:54 AM GMT

    Decision Of Which Vaccine Goes To Which Site Left To State Govts

    The decision of whether a vaccination site receives COVISHIELD or COVAXIN in a state was taken by the state and union territory governments, Health Secretary Rajesh Bhushan said in a press conference. 

    State governments decided which vaccine they wanted to administer at their respective vaccination sites. Several states ordered both COVISHIELD as well as COVAXIN  to distribute within the states. 


  • 19 Jan 2021 10:51 AM GMT

    Bharat Biotech Releases List Of People Who Should Not Receive Covaxin

    In a fact sheet uploaded on its website, COVAXIN producer Bharat Biotech has released a list of participants that should not receive its COVID-19 vaccine. 

    People with allergies, suffering from fever at the time of vaccination, having a bleeding disorder or consuming a blood thinner, on medication for a disorder that affects the immunity, pregnant, and lactating should avoid the COVAXIN dose. 

    While pregnant and lactating women avoiding the vaccine is in tune with the guidelines of the government, Bharat Biotech has also included people suffering from other health conditions. 

Show Full Article
Next Story